By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


SEARCH JOBS

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

YEAR FOUNDED:

1858

LEADERSHIP:

Founder: Edward Robinson Squibb

CEO: Giovanni Caforio, MD

CFO: Charles Bancroft

CLINICAL TRIAL:

Please click here for clinical trial information.

JOB OPPORTUNITY:

Please click here for Bristol-Myers Squibb job opportunities.

PRODUCTS:

Please click here to see all products.

For more information, visit
www.bms.com and follow us on www.twitter.com/BMSNEWS.

FOLLOW BRISTOL-MYERS SQUIBB:





Key Statistics


Email:
Ownership: Public

Web Site: Bristol-Myers Squibb
Employees:
Symbol: BMY
 





Collaborations

Gilead 

PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech  - Cancer

Gilead (Seattle, WA) 





Company News
Bristol-Myers Squibb (BMY) Release: Japan Ministry Of Health, Labor And Welfare Approves Opdivo (Nivolumab) For The Treatment Of Patients With Unresectable Advanced Or Recurrent Gastric Cancer Which Has Progressed After Chemotherapy 9/22/2017 6:51:20 AM
AbbVie (ABBV) And Bristol-Myers Squibb (BMY) Announce Clinical Research Collaboration To Evaluate A Therapeutic Regimen In Advanced Solid Tumors 9/22/2017 6:23:46 AM
Bristol-Myers Squibb (BMY) Release: New Global Report Finds Majority Of People At High Risk Of Stroke Not Being Screened For Common Risk Factors 9/21/2017 7:18:43 AM
Bristol-Myers Squibb (BMY) To Take Part In Leerink Partners Rare Disease & Immuno-Oncology Roundtable Conference 9/21/2017 6:46:34 AM
Bristol-Myers Squibb (BMY) Stock Still A Beast? 9/19/2017 6:30:26 AM
Who Will Win The Kidney Cancer Battle Between Bristol-Myers Squibb (BMY) And Exelixis (EXEL)? 9/15/2017 5:59:37 AM
Bristol-Myers Squibb (BMY) Names Karen Vousden, Ph.D. To Board Of Directors 9/14/2017 7:02:43 AM
Bristol-Myers Squibb (BMY) Announces Dividend 9/14/2017 7:01:00 AM
San Diego's Halozyme (HALO) Lands Monster R&D Deals Worth $2 Billion+ From Bristol-Myers Squibb (BMY) and Roche (RHHBY) 9/14/2017 5:52:56 AM
Bristol-Myers Squibb (BMY) Release: Opdivo (Nivolumab) Demonstrates Superior Recurrence-Free Survival Versus Yervoy (Ipilimumab) For Patients With Resected High-Risk Melanoma In Phase III Checkmate -238 Study 9/11/2017 7:36:49 AM
12345678910...
//-->